オノ コウジ
ONO Koji
小野 公嗣 所属 埼玉医科大学 保健医療学部 臨床検査学科 職種 准教授 |
|
論文種別 | 学術雑誌(原著) |
言語種別 | 英語 |
査読の有無 | 査読あり |
表題 | Chlorpromazine oligomer is a potentially active substance that inhibits human D-amino acid oxidase, product of a susceptibility gene for schizophrenia |
掲載誌名 | 正式名:JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY ISSNコード:14756366 |
出版社 | INFORMA HEALTHCARE |
巻・号・頁 | 23(6),901-911頁 |
著者・共著者 | Sanae Iwana,Tomoya Kawazoe,Hwan Ki. Park,Koichiro Tsuchiya,Koji Ono,Kazuko Yorita,Takashi Sakai,Takenori Kusumi,Kiyoshi Fukui |
発行年月 | 2008 |
概要 | D-Amino acid oxidase (DAO), a potential risk factor for schizophrenia, has been proposed to be involved in the decreased glutamatergic neurotransmission in schizophrenia. Here we show the inhibitory effect of an antipsychotic drug, chlorpromazine, on human DAO, which is consistent with previous reports using porcine DAO, although human DAO was inhibited to a lesser degree (Ki=0.7mM) than porcine DAO. Since chlorpromazine is known to induce phototoxic or photoallergic reactions and also to be transformed into various metabolites, we examined the effects of white light-irradiated chlorpromazine on the enzymatic activity. Analytical methods including high-resolution mass spectrometry revealed that irradiation triggered the oligomerization of chlorpromazine molecules. The oligomerized chlorpromazine showed a mixed type inhibition with inhibition constants of low micromolar range, indicative of enhanced inhibition. Taken together, these results suggest that oligomerized chlorpromazine could act as an active substance that might contribute to the therapeutic effects of this drug. |
DOI | 10.1080/14756360701745478 |